IL171893A0 - Dispersible pharmaceutical composition for treatment of mastitis and otic disorders - Google Patents

Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Info

Publication number
IL171893A0
IL171893A0 IL171893A IL17189305A IL171893A0 IL 171893 A0 IL171893 A0 IL 171893A0 IL 171893 A IL171893 A IL 171893A IL 17189305 A IL17189305 A IL 17189305A IL 171893 A0 IL171893 A0 IL 171893A0
Authority
IL
Israel
Prior art keywords
mastitis
treatment
pharmaceutical composition
otic disorders
dispersible pharmaceutical
Prior art date
Application number
IL171893A
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of IL171893A0 publication Critical patent/IL171893A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)
IL171893A 2003-07-31 2005-11-10 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders IL171893A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49217803P 2003-07-31 2003-07-31
PCT/IB2004/002474 WO2005009472A2 (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Publications (1)

Publication Number Publication Date
IL171893A0 true IL171893A0 (en) 2006-04-10

Family

ID=34103028

Family Applications (1)

Application Number Title Priority Date Filing Date
IL171893A IL171893A0 (en) 2003-07-31 2005-11-10 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Country Status (13)

Country Link
EP (1) EP1656159A2 (en)
JP (1) JP2007500692A (en)
KR (1) KR100807414B1 (en)
CN (1) CN1812814A (en)
AU (1) AU2004258746A1 (en)
BR (1) BRPI0412923A (en)
CA (1) CA2529405A1 (en)
IL (1) IL171893A0 (en)
MX (1) MXPA06001192A (en)
NO (1) NO20055466L (en)
RU (1) RU2329064C2 (en)
WO (1) WO2005009472A2 (en)
ZA (1) ZA200600850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012215A (en) * 2004-04-22 2007-04-19 Pfizer Prod Inc Method of stabilizing disordered cefovecin sodium salt.
WO2014001353A1 (en) * 2012-06-29 2014-01-03 Bayer Animalhealth Gmbh Pharmaceutical compositions and treatment of mastitis
MX2016001912A (en) * 2013-08-12 2016-06-02 Novartis Ag Method for treating otic infections after tympanostomy tube placement.
CN104622875B (en) * 2015-02-12 2017-05-10 江西博莱大药厂有限公司 Breast injection medicament for resisting cow mastitis and preparation method thereof
AU2016350868B2 (en) * 2015-11-03 2022-03-31 Zoetis Services Llc Sol-gel polymer composites and uses thereof
RU2663070C1 (en) * 2017-05-04 2018-08-01 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Method for otomycosis treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0782448T3 (en) * 1995-06-06 2002-07-08 Bayer Ag Non-irritating, non-sensitizing, non-ototoxic antibacterial ear preparations
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid

Also Published As

Publication number Publication date
MXPA06001192A (en) 2006-04-11
AU2004258746A1 (en) 2005-02-03
JP2007500692A (en) 2007-01-18
WO2005009472A3 (en) 2005-04-07
RU2006102665A (en) 2006-06-10
CA2529405A1 (en) 2005-02-03
BRPI0412923A (en) 2006-09-26
KR20060033031A (en) 2006-04-18
RU2329064C2 (en) 2008-07-20
KR100807414B1 (en) 2008-02-25
WO2005009472A2 (en) 2005-02-03
NO20055466L (en) 2006-04-21
EP1656159A2 (en) 2006-05-17
CN1812814A (en) 2006-08-02
NO20055466D0 (en) 2005-11-18
ZA200600850B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
PT1644021E (en) Methods and compositions for the treatment of gastrointestinal disorders
IL175529A0 (en) Methods and compositions for the treatment of metabolic disorders
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
PT2359856T (en) Formulation of human antibodies for treating tnf-alpha associated disorders
EP1737453A4 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
IL178730A0 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
IL177772A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
IL175425A0 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
AU2002252373A1 (en) Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
EP1699431A4 (en) Compositions for treatment of ear disorders and methods of use thereof
HUP0600781A2 (en) Compounds for the treatment of metabolic disorders and pharmaceutical compositions containing them
HUP0202719A3 (en) Pharmaceutical compositions for the treatment of female sexual dysfunctions
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2003286741A8 (en) Methods and compositions for diagnosis and therapy of parkin-associated disorders
EP1638938A4 (en) Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
EP1680145A4 (en) Methods and compositions for the treatment of neurological disease
EP1648417A4 (en) Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
IL171893A0 (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
EP1478438A4 (en) Methods and compositions for the treatment of asthma and related disorders
EP1651255A4 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
EP1660101A4 (en) Liquid formulations for the prevention and treatment of mucosal diseases and disorders